PHM:NYSEPulteGroup, Inc. Analysis
Data as of 2026-03-10 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
PulteGroup is trading around $126, notably above its DCF‑derived fair value estimate, suggesting the market may be pricing in optimistic expectations. The stock sits just above its 200‑day moving average but below the 20‑ and 50‑day averages, and the RSI of roughly 36 hints at a modest oversold condition. Technical momentum is mixed, with a bearish MACD histogram and a stable volume pattern, while the broader market sentiment is in the "Extreme Greed" zone. Recent material news highlights the successful pricing of an $800 million senior note offering, reinforcing the company's ability to access capital and refinance debt at attractive rates. Analysts collectively rate the stock as a "Buy" with a median target near $145, reflecting confidence in the firm’s strategic land‑management focus. Fundamentally, PHM delivers solid profitability margins, a low payout ratio under 10%, and ample operating cash flow, supporting dividend sustainability. However, revenue has contracted year‑over‑year, and the homebuilding sector remains sensitive to macro‑economic cycles. The beta of 0.71 points to lower systematic risk, yet 30‑day volatility near 30% signals price swings. Overall, the valuation appears stretched relative to intrinsic calculations, but the defensive dividend profile and strong balance sheet temper downside concerns.
Market Outlook
Short Term
< 1 yearKey Factors
- Price near recent support levels with limited upside
- Bearish MACD and mixed moving‑average positioning
- Stable volume suggesting no immediate breakout
Medium Term
1–3 yearsKey Factors
- Analyst consensus target above current price
- Low payout ratio and strong cash flow supporting dividend
- Strategic land‑management initiatives driving future growth
Long Term
> 3 yearsKey Factors
- Cyclical exposure of residential construction sector
- Sustainable dividend with modest payout
- Current valuation above intrinsic fair value
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.